Long-Term and Significant Correction of Brain Lesions in Adult Mucopolysaccharidosis Type VII Mice Using Recombinant AAV Vectors
Open Access
- 1 January 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (1) , 63-70
- https://doi.org/10.1006/mthe.1999.0005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vectorGene Therapy, 1999
- Extensiveβ-Glucuronidase Activity in Murine Central Nervous System after Adenovirus-Mediated Gene Transfer to BrainHuman Gene Therapy, 1998
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.Journal of Clinical Investigation, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous SystemExperimental Neurology, 1997
- Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brainNature, 1995
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973